Unknown NA INTERVENTIONAL 1-arm NCT03220464

Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT

Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts

Sponsor: Seoul National University Hospital

Conditions Latent Tuberculosis Tuberculosis, Pulmonary

Interventions Chest X-ray Interferon-gamma Release Assay (IGRA) Ultra low dose chest computed tomography (ULDCT)

Updated 7 times since 2017 Last updated: Jul 18, 2017 Started: Jun 20, 2017 Primary completion: Apr 30, 2019 Completion: Apr 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Latent Tuberculosis and Tuberculosis, Pulmonary and is currently ongoing. Seoul National University Hospital leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jun 2020 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea